Sanoral

Medicinal product

(Invented) name

Sanoral

Active substance (s)

Olmesartanas medoksomilis/Amlodipinas

Strength

20 mg/5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09DB02, Olmesartan medoxomil and amlodipine

Marketing authorisation holder

Menarini International Operations Luxembourg S.A., Liuksemburgas

Date of authorisation

2008-11-27

Date of renewal

2013-08-13

Documents

1363 Sanoral 20_5 PCS PL 2025 01 17.docx

1363 Pakuotės lapelis 20mg_5mg 2025 01 17.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10b

Procedure number

NL/H/1115/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Olmesartanas medoksomilis	20 mg
Amlodipinas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
23604	26294	1026294	lizdinė plokštelė	N14		Receptinis	LT/1/08/1363/001	Netiekiama	-	-	No	-	-
23979	26655	1026655	lizdinė plokštelė	N28		Receptinis	LT/1/08/1363/002	Tiekiama	-	-	No	-	-	Download
23980	26656	1026656	lizdinė plokštelė	N56		Receptinis	LT/1/08/1363/003	Netiekiama	-	-	No	-	-
23981	26657	1026657	lizdinė plokštelė	N98		Receptinis	LT/1/08/1363/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2013-08-13	Perregistruotas
2008-11-27	Registruotas